Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication
Published by Elsevier Inc..
Human butyrylcholinesterase (E.C. 3.1.1.8) purified from blood plasma has previously been shown to provide protection against up to five and a half times the median lethal dose of an organophosphorus nerve agent in several animal models. In this study the stoichiometric nature of the protection afforded by human butyrylcholinesterase against organophosphorus nerve agents was investigated in guinea pigs. Animals were administered human butyrylcholinesterase (26.15 mg/kg ≡ 308 nmol/kg) by the intravascular or intramuscular route. Animals were subsequently dosed with either soman or VX in accordance with a stage-wise adaptive dose design to estimate the modified median lethal dose in treated animals. Human butyrylcholinesterase (308 nmol/kg) increased the median lethal dose of soman from 154 nmol/kg to 770 nmol/kg. Comparing the molar ratio of agent molecules to enzyme active sites yielded a stoichiometric protective ratio of 2:1 for soman, likely related to the similar stereoselectivity the enzyme has compared to the toxic target, acetylcholinesterase. In contrast, human butyrylcholinesterase (308 nmol/kg) increased the median lethal dose of VX from 30 nmol/kg to 312 nmol/kg, resulting in a stoichiometric protective ratio of only 1:1, suggesting a lack of stereoselectivity for this agent.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:171 |
|---|---|
| Enthalten in: |
Biochemical pharmacology - 171(2020) vom: 21. Jan., Seite 113670 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cerasoli, Douglas M [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 27.07.2020 Date Revised 27.07.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bcp.2019.113670 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM302352139 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM302352139 | ||
| 003 | DE-627 | ||
| 005 | 20231225110535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bcp.2019.113670 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1007.xml |
| 035 | |a (DE-627)NLM302352139 | ||
| 035 | |a (NLM)31628910 | ||
| 035 | |a (PII)S0006-2952(19)30369-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cerasoli, Douglas M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.07.2020 | ||
| 500 | |a Date Revised 27.07.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a Human butyrylcholinesterase (E.C. 3.1.1.8) purified from blood plasma has previously been shown to provide protection against up to five and a half times the median lethal dose of an organophosphorus nerve agent in several animal models. In this study the stoichiometric nature of the protection afforded by human butyrylcholinesterase against organophosphorus nerve agents was investigated in guinea pigs. Animals were administered human butyrylcholinesterase (26.15 mg/kg ≡ 308 nmol/kg) by the intravascular or intramuscular route. Animals were subsequently dosed with either soman or VX in accordance with a stage-wise adaptive dose design to estimate the modified median lethal dose in treated animals. Human butyrylcholinesterase (308 nmol/kg) increased the median lethal dose of soman from 154 nmol/kg to 770 nmol/kg. Comparing the molar ratio of agent molecules to enzyme active sites yielded a stoichiometric protective ratio of 2:1 for soman, likely related to the similar stereoselectivity the enzyme has compared to the toxic target, acetylcholinesterase. In contrast, human butyrylcholinesterase (308 nmol/kg) increased the median lethal dose of VX from 30 nmol/kg to 312 nmol/kg, resulting in a stoichiometric protective ratio of only 1:1, suggesting a lack of stereoselectivity for this agent | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a Bioscavenger | |
| 650 | 4 | |a Butyrylcholinesterase | |
| 650 | 4 | |a Nerve agent | |
| 650 | 4 | |a Prophylaxis | |
| 650 | 4 | |a Stoichiometry | |
| 650 | 7 | |a Chemical Warfare Agents |2 NLM | |
| 650 | 7 | |a Nerve Agents |2 NLM | |
| 650 | 7 | |a Neuroprotective Agents |2 NLM | |
| 650 | 7 | |a Organothiophosphorus Compounds |2 NLM | |
| 650 | 7 | |a Soman |2 NLM | |
| 650 | 7 | |a 96-64-0 |2 NLM | |
| 650 | 7 | |a VX |2 NLM | |
| 650 | 7 | |a 9A4381183B |2 NLM | |
| 650 | 7 | |a Butyrylcholinesterase |2 NLM | |
| 650 | 7 | |a EC 3.1.1.8 |2 NLM | |
| 700 | 1 | |a Armstrong, Stuart J |e verfasserin |4 aut | |
| 700 | 1 | |a Reeves, Tony E |e verfasserin |4 aut | |
| 700 | 1 | |a Hodgins, Sean M |e verfasserin |4 aut | |
| 700 | 1 | |a Kasten, Shane A |e verfasserin |4 aut | |
| 700 | 1 | |a Lee-Stubbs, Robyn B |e verfasserin |4 aut | |
| 700 | 1 | |a Cadieux, C Linn |e verfasserin |4 aut | |
| 700 | 1 | |a Otto, Tamara C |e verfasserin |4 aut | |
| 700 | 1 | |a Capacio, Benedict R |e verfasserin |4 aut | |
| 700 | 1 | |a Lenz, David E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biochemical pharmacology |d 1959 |g 171(2020) vom: 21. Jan., Seite 113670 |w (DE-627)NLM000000094 |x 1873-2968 |7 nnns |
| 773 | 1 | 8 | |g volume:171 |g year:2020 |g day:21 |g month:01 |g pages:113670 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bcp.2019.113670 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 171 |j 2020 |b 21 |c 01 |h 113670 | ||